I hate this. "The market only allows people to bet on the outcomes of Phase 3 trials run by established biopharma companies and on full approval decisions by the FDA—not on early-stage trials or conditional approvals, but it could expand the market down the line." www.forbes.com/sites/maryro...
Kalshi Is Letting People Bet On Clinical Trials And FDA Drug DecisionsGamblers can now bet on how experimental drugs will perform in clinical trials—and if they’ll get FDA approval.www.forbes.com